Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 293

Total Visits per Month

June 2017 July 2017 August 2017 September 2017 October 2017 November 2017 December 2017
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 0 8 5 3 6 3 0

File Downloads

Views
dce-mri abstract.pdf 43

Top Country Views

Views
United States 67
Canada 53
France 46
United Kingdom 11
China 9
Russia 9
Germany 7
Sweden 6
Netherlands 5
Italy 3

Top City Views

Views
Calgary 26
Miami Beach 23
Toronto 12
Ottawa 9
Nynäs 6
Santa Clara 6
Zhengzhou 6
Kansas City 5
Plano 4
Dundas 3